DealShare's $1.7B Unicorn Value Is Basically Its Cash Now
Truemeds is in talks to acquire DealShare for about $90 million in an all-stock deal, 95% below DealShare's 2022 unicorn peak. The real story is how much Truemeds' own valuation had to inflate to make it work.